United Kingdom 6 December 2015 Text size Home - UK About us and Orion Products & Services News Careers Contact us Orion.fi Home - UK / Careers Employee wellbeing, competence development and precise resource planning are human resource management objectives at Orion. To read more, click here. If you would like to express an interest in working for Orion Pharma (UK) please write with your CV enclosed. Orion Pharma (UK) Ltd., Oaklea Court Park Street, Newbury, Berkshire RG141EA 2014 Copyright Orion Pharma - ORI3784a(3) March 2015 Home - UK Internet policy Sitemap Contact us

United Kingdom 16 September 2015 Text size Home - UK About us and Orion Products & Services News Careers Contact us Orion.fi Overactive Bladder Asthma Disorders of the Prostate Parkinson's Disease Menopause Home - UK / Products & Services / Disorders of the Prostate / 10 Facts About Prostate Cancer Print The Facts 10 Facts About Prostate Cancer The prostate is a walnut sized gland that sits beneath the bladder and surrounding the urethra. It increases in size throughout life, with a particular growth during adolescents. Its function is to secrete prostatic fluid, a fluid that makes up 25% of semen. Prostate cancer is the most common type of male cancer in Europe after lung cancer. Some 300,000 new cases are diagnosed in Europe each year. Prostate cancer is the most commonly diagnosed cancer in men in the UK. It accounts for one quarter of all new cancers diagnosed in men. Age is a major risk factor for the disease. The disease is common in older men. Cases among those under 50 are diagnosed rarely. Although prostate cancer rates have tripled over the last 30 years, much of this increase is due to increased awareness, testing and detection of the disease. Men of Afro-Caribbean/ African origin have higher risks of prostate cancer than white men. Men born in Asia have lower risks of prostate cancer than men born in the UK. Symptoms can be similar to the urination problems experienced in benign prostate hyperplasia (enlargement) or ‘BPH’. This condition is non-cancerous. The prognosis is reasonably good, with three quarters of men surviving for more than five years after diagnosis. Prostate cancer is diagnosed by clinical examination and laboratory tests. If necessary, prostate biopsies are taken. Treatment for prostate cancer is always decided case by case. If the cancer is local, the aim is to cure the disease. If the cancer has spread, the aim is to slow down or stop its progress. Treatment is not always necessary. If the prostate cancer is local and the outlook or prognosis is good, it is sometimes sufficient to keep monitoring the illness. Updated 3 March 2010 Orion Pharma (UK) Ltd., Oaklea Court Park Street, Newbury, Berkshire RG141EA 2014 Copyright Orion Pharma - ORI3784a(3) March 2015 Home - UK Internet policy Sitemap Contact us